Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550) |
---|
03/02/2004 | US6699893 Glucocorticoid receptor modulators |
03/02/2004 | US6699891 Npyy5 antagonists |
03/02/2004 | US6699887 Administering a therapeutically effective amount of a pyrrazole sulfide or ether compound to treat the human immunodeficiency virus infection |
03/02/2004 | US6699884 Antiinflammatory cyclooxygenase inhibitors. |
03/02/2004 | US6699865 Protein kinase inhibitors, for treating cancer inflammatory disorders, restenosis, and cardiovascular disease. |
03/02/2004 | US6699651 Base precursors for use in a photothermographic element |
02/26/2004 | WO2004016741A2 Prenylation inhibitors containing dimethyl-cyclobutane and methods of their synthesis and use |
02/26/2004 | WO2004016709A1 Luminescent spiro-dimer and organic light-emitting device comprising the same |
02/26/2004 | WO2004016596A1 Condensed heterocyclic compounds as pde-iv inhibitors for the treatment of inflammatory and allergic disorders |
02/26/2004 | WO2004016592A1 Prenylation inhibitors and methods of their synthesis and use |
02/26/2004 | WO2004016576A1 Fused benzene derivative and use |
02/26/2004 | WO2003094854A3 Succinoyl aminopyrazoles and related compounds |
02/26/2004 | WO2003050261A3 (1-phenyl-2-heteroaryl)ethyl-guanidine compounds as inhibitors of mitochondrial f1f0 atp hydrolase |
02/26/2004 | WO2003039549A8 Selective antibacterial agents |
02/26/2004 | US20040039043 Amidobiphenyloxime derivatives, useful as fungicide or bactericide for protection of crops and materials |
02/26/2004 | US20040039033 Administering (1-phenyl-2-heteroaryl)ethyl-guanidine compounds for treating ischemic conditions including myocardial infarction, congestive heart failure, and cardiac arrhythmias |
02/26/2004 | US20040039025 Substituted hydrazine derivatives |
02/26/2004 | US20040039024 Pyrazolecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them |
02/26/2004 | US20040038969 Substituted aminopyrimidines and aminopyridazines; analgesics particularly for migraines, neuropathic pain and associated hyperalgesia and allodynia; antiinflammatory agents; treating asthma, gastrointestinal disorders, etc. |
02/26/2004 | US20040037022 Aminoalcohol derivatives |
02/26/2004 | CA2495383A1 Fused benzene derivative and use |
02/25/2004 | EP1391952A2 Salts of pentacyclic or tetrapentaline derived anions, and their uses as ionic conductive materials |
02/25/2004 | EP1391450A1 N-(heterocycle-methyl)alkylamine derivative, process for producing the same, and bactericide |
02/25/2004 | EP1390340A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
02/25/2004 | EP1181269B1 Cell proliferation inhibitors |
02/25/2004 | EP1005446B1 N-aroylphenylalanine derivatives |
02/25/2004 | EP0918756B1 Parasiticidal pyrazoles |
02/25/2004 | CN1478080A Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
02/25/2004 | CN1478079A Diaminopyrazole derivatives and their use for oxidation dyeing of keratinous fibres |
02/25/2004 | CN1139580C Substituted benzylamines and their use for treatment of depression |
02/24/2004 | US6696477 Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
02/19/2004 | WO2004014871A1 Vanilloid receptor ligands and their use in treatments |
02/19/2004 | WO2004014864A1 1h-indazole-3-carboxamide compounds as cyclin dependent kinases (cdk) inhibitors |
02/19/2004 | WO2004014863A1 Benzoylpyrazolones substituted by 3-aminocarbonyl |
02/19/2004 | WO2004014844A2 Aryl and heteroaryl compounds and methods to modulate coagulation |
02/19/2004 | WO2004014842A1 Acylated arylcycloalkylamines and their use as pharmaceuticals |
02/19/2004 | WO2004014430A1 Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasia |
02/19/2004 | WO2004014352A2 Methods for treating carbonic anhydrase mediated disorders |
02/19/2004 | WO2003057213A3 Cyclohexano- and cycloheptapyrazole derivative compounds, for use in diseases associated with the 5-ht2c receptor |
02/19/2004 | US20040034234 Adding sulfur dioxide to a mixture containing a cyanopyrazole 4-yl disulfide compound, a formate salt, trifluoromethyl bromide and a polar solvent to form 4-trifluoromethylthiopyrazole compound |
02/19/2004 | US20040034084 Side effect reduction; for treatment of AIDS, cancer and arthritis |
02/19/2004 | US20040034082 Utilization of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of proliferative cell diseases |
02/19/2004 | US20040034081 Estrogen receptor modulators |
02/19/2004 | US20040034069 Nitrogen-containing compounds and their use as glycine transport inhibitors |
02/19/2004 | US20040034025 Having a high residual activity, greater activity at lower application rates, curative activity, and a broader spectrum of efficacy; heterocyclic aromatic amides having a hydroxy group adjacent to the amide functionality |
02/19/2004 | DE10235945A1 New 4-(3-substituted benzoyl)-pyrazol-5-one derivatives, useful as broad-spectrum, pre- and post-emergence herbicides especially for selective weed control in crops e.g. wheat, maize and rice |
02/19/2004 | CA2495516A1 Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasia |
02/19/2004 | CA2495502A1 Methods for treating carbonic anhydrase mediated disorders |
02/19/2004 | CA2493008A1 Aryl and heteroaryl compounds and methods to modulate coagulation |
02/18/2004 | EP1389190A1 Diamide invertebrate pest control agents containing a non-aromatic heterocyclic ring |
02/18/2004 | EP1389100A2 Novel methods for the treatment and prevention of pain using stress-activated protein kinase inhibitors |
02/18/2004 | EP1286953B1 (p-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds |
02/18/2004 | CN1476424A 萘衍生物 Naphthalene Derivatives |
02/18/2004 | CN1138760C Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
02/18/2004 | CN1138756C Process for preparation of tirt nitrile substituted aromatic compound |
02/12/2004 | WO2004013107A1 Drugs for preventing and/or treating spinal injury |
02/12/2004 | WO2004013106A1 Pyrazole derivatives and process for the production thereof |
02/12/2004 | WO2004013094A2 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
02/12/2004 | WO2003070236A3 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents |
02/12/2004 | WO2003049702A3 Vanilloid receptor ligands and their use in treatments |
02/12/2004 | US20040030151 Stable amorphous celecoxib composite and process therefor |
02/12/2004 | US20040030140 Process for preparing pesticidal intermediates |
02/12/2004 | US20040030132 Anticancer agents; arterosclerosis; bone disorders; antiarthritic agents; vision defects |
02/12/2004 | US20040029946 Topical applying |
02/12/2004 | US20040029933 Substituted phenylacetic acids |
02/12/2004 | US20040029886 Dihalopropene compounds, processes for their preparation, compositions comprising them and their use as pesticides |
02/12/2004 | US20040027821 Pyrazolone lanthanide complexes |
02/12/2004 | CA2494404A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
02/11/2004 | EP1388535A1 Acylated arylcycloalkylamines and their use as pharmaceuticals |
02/11/2004 | EP1387831A1 Substituted arylketones |
02/11/2004 | CN1474803A Novel amide derivatives and medicinal use thereof |
02/11/2004 | CN1473831A Process for preparing pyrazolo (4,3-d) pyrimidine-7-ketone and its intermediate |
02/11/2004 | CN1137884C Indazole compounds and pharmaceutical compositions for inhibiting protein kinases and methods for their use |
02/10/2004 | US6689805 Treatment of pain, inflammation, fever, cancer and dementia |
02/10/2004 | US6689773 Uracil substituted phenyl sulfamoyl carboxamides |
02/05/2004 | WO2004011453A2 Method for preparing 3-halo-4,5-dihydro-1h-pyrazoles |
02/05/2004 | WO2004011446A1 Indane, dihydrobenzofuran, and tetrahydronaphthalene carboxylic acid derivatives and their use as antidiabetics |
02/05/2004 | WO2004011444A2 Novel method for preparing styryl pyrazole, isoxazole and isothiazole derivatives |
02/05/2004 | WO2004010995A1 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthristis |
02/05/2004 | WO2004010945A2 Cyclooxygenase- 2 selective inhibitors, compositions and methods of use |
02/05/2004 | WO2004010785A1 A series of n-phenylpyrazole derivatives insecticide compounds |
02/05/2004 | WO2003075857A3 Amino-methyl substituted tetracycline compounds |
02/05/2004 | WO2003074475A3 Substituted aryl ketones |
02/05/2004 | US20040024225 Forming 1-(4-sulfonylphenyl)pyrazole from condensation of diketones and hydrazines; crystallization; for production of celecoxib |
02/05/2004 | US20040024215 Such as 4'-trifluoromethyl-biphenyl-2-carboxylic acid(4-(4-(alpha-methyl-benzyl)-piperazin-1-yl)-phenyl)-amide; apoprotein B-100 (apoB-100) and microsomal triglyceride transfer protein (MTP) |
02/05/2004 | US20040024208 Cyclic protein tyrosine kinase inhibitors |
02/05/2004 | US20040024205 Monomethylation of nitrogeneous heterocycles |
02/05/2004 | US20040024059 Novel pleuromutilin derivatives |
02/05/2004 | US20040024041 Dermal therapeutic system containing non-steroidal antiphlogistics with selective cox-2 inhibition |
02/05/2004 | US20040024040 Inhibitors of GSK-3 and uses thereof |
02/05/2004 | US20040024030 Such as 4-chloro-5-(2-phenyl-thiazol-5-yl)-2H-pyrazole-3-carboxylic acid ethyl amide; for inhibiting topoisomerases; treating bacterial infections in mammals |
02/05/2004 | US20040023999 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
02/05/2004 | US20040023806 Agrochemicals in agriculture for controlling acarids and insects and for preventing the infestation of crop plants by phytopathogenic fungi. |
02/05/2004 | DE10231627A1 New 1-benzoyl-3-(heterocyclyl-phenyl)-urea derivatives, are glycogen phosphorylase a inhibitors useful e.g. for treating type II diabetes, dyslipidemia or arteriosclerosis |
02/05/2004 | DE10230780A1 Verfahren zur Herstellung von 1-Methylcyclopropylguanidin bzw. dessen Salzen A process for the preparation of 1-Methylcyclopropylguanidin or its salts |
02/05/2004 | DE10148618A1 Substituierte N-(1,4,5,6-Tetrahydro-cyclopentapyrazol-3-yl)-Derivate, deren Herstellung und Verwendung als Arzneimittel Substituted N- (1,4,5,6-tetrahydro-cyclopentapyrazol-3-yl) derivatives, their preparation and use as medicaments |
02/05/2004 | CA2493156A1 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
02/04/2004 | EP1386916A1 Process for the monomethylation of nitrogen containing heterocycles |
02/04/2004 | EP1386915A1 Azole compounds, process for preparation of the same and use thereof |
02/04/2004 | EP1386606A1 Stable high− concentration injection containing pyrazolone derivative |